Aly-Khan A. Lalani, Department of Medical Oncology, Cross Cancer Institute, University of Alberta presents Proton Pump Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma (mRCC) at the 2016 annual International Kidney Cancer Symposium.
Proton Pump Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma (mRCC)
